Skip to main content
Clinical Trials/NCT04959136
NCT04959136
Not Yet Recruiting
N/A

Feasibility Study Of Ambulatory Monitoring System

GE Healthcare0 sites300 target enrollmentSeptember 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patient Monitoring
Sponsor
GE Healthcare
Enrollment
300
Primary Endpoint
User feedback
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

This is a clinical, data collection study conducted at one site. This study will collect open comments, user feedback and parameter raw data to support patient monitoring product development. Subjects participating in this study will be monitored with the site's standard of care primary monitor and the investigational device as the secondary monitor while enrolled in this study. No subject care decisions or diagnoses will be made based on information obtained from the investigational secondary monitor.

Detailed Description

This is a pre-market, open label, prospective, non-randomized, data collection clinical research study conducted at one investigational site. This study will collect open comments, user feedback and parameter raw data to support product development. Raw parameter data will be collected from electrocardiogram (ECG), Pulse Rate (PR), respiratory rate (RR), peripheral capillary oxygen saturation (SpO2), non-invasive blood pressure (NIBP), and temperature. Subjects participating in this study will be monitored with the site's standard of care primary monitor and the investigational device as the secondary monitor while enrolled in this study. No subject care decisions or diagnoses will be made based on information obtained from the investigational secondary monitor. Participation is expected to last no more than 72 hours.

Registry
clinicaltrials.gov
Start Date
September 1, 2021
End Date
December 30, 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Are able to provide written informed consent or have a legally designated representative provide written informed consent;
  • Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure; AND
  • Are an adult 18 years or older, or pediatric or neonate subject.

Exclusion Criteria

  • Are known to be pregnant;
  • Are breastfeeding; OR
  • Are suffering from infections that require isolation.

Outcomes

Primary Outcomes

User feedback

Time Frame: through study completion, average of one day per subject

This is an early feasibility study intended to elicit user feedback in a hospital setting in order to improve device functionality and further development of the measurement algorithms. User feedback will be collected by open comments field in CRF.

Collection of electronic parameter data

Time Frame: 2 hours up to 3 days

Electronic device files from patient sensors will be collected for each subject.

Secondary Outcomes

  • Safety information(through study completion and issues resolved, average of one day per subject)

Similar Trials